dc.contributor.author | Kaymakoglu, Sabahattin | |
dc.contributor.author | Demir, Kadir | |
dc.contributor.author | Besisik, Fatih | |
dc.contributor.author | Akyuz, Filiz | |
dc.contributor.author | Baran, Bulent | |
dc.contributor.author | Gokturk, Suut | |
dc.contributor.author | Karaca, Cetin | |
dc.contributor.author | Ormeci, Asli C. | |
dc.contributor.author | Evirgen, Sami | |
dc.contributor.author | Aydin, Esra | |
dc.contributor.author | Soyer, Ozlem M. | |
dc.date.accessioned | 2021-03-02T22:18:20Z | |
dc.date.available | 2021-03-02T22:18:20Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Karaca C., Soyer O. M. , Baran B., Ormeci A. C. , Gokturk S., Aydin E., Evirgen S., Akyuz F., Demir K., Besisik F., et al., "Efficacy of pegylated interferon-atreatment for 24 months in chronic delta hepatitis and predictors of response", Antiviral Therapy, cilt.18, sa.4, ss.561-566, 2013 | |
dc.identifier.issn | 1359-6535 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_0bf13f8f-2fb0-44f3-b854-75ed69d1130d | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/13686 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84885348949&origin=inward | |
dc.identifier.uri | https://doi.org/10.3851/imp2381 | |
dc.description.abstract | Background: To determine the efficacy of pegylated interferon-alpha (PEG-IFN-alpha) therapy for 24 months in chronic delta hepatitis (CDH). | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.subject | İmmünoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | VİROLOJİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Mikrobiyoloji ve Klinik Mikrobiyoloji | |
dc.subject | Viroloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.title | Efficacy of pegylated interferon-atreatment for 24 months in chronic delta hepatitis and predictors of response | |
dc.type | Makale | |
dc.relation.journal | Antiviral Therapy | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 561 | |
dc.identifier.endpage | 566 | |
dc.contributor.firstauthorID | 207418 | |